Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Penumbra Inc One Penumbra Place Alameda CA 94502 USA

P: 510-748-3200 F: 510-748-3232

Description:

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Key Statistics

Overview:

Market Capitalization, $K 6,915,318
Enterprise Value, $K 6,660,438
Shares Outstanding, K 37,888
Annual Sales, $ 747,590 K
Annual Net Income, $ 5,280 K
Last Quarter Sales, $ 208,340 K
Last Quarter Net Income, $ -3,690 K
60-Month Beta 0.66
% of Insider Shareholders 5.50%
% of Institutional Shareholders 81.65%
Float, K 35,804
% Float 94.50%
Short Volume Ratio 0.80

Growth:

1-Year Return -31.79%
3-Year Return 24.95%
5-Year Return 93.76%
5-Year Revenue Growth 183.91%
5-Year Earnings Growth 56.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 08/04/22
Next Earnings Date 11/02/22
Earnings Per Share ttm 0.22
EPS Growth vs. Prev Qtr 200.00%
EPS Growth vs. Prev Year -95.24%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PEN Ratios

Ratio
Price/Earnings ttm 840.64
Price/Earnings forward 754.86
Price/Earnings to Growth N/A
Return-on-Equity % 0.97%
Return-on-Assets % 0.71%
Profit Margin % 0.71
Net Margin % N/A
Debt/Equity 0.03
Price/Sales 9.37
Price/Cash Flow 161.70
Price/Book 7.22
Book Value/Share 25.60
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar